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An E. coli essential gene screen reveals targeting rules for BzCas13b
To validate the expected interference activity of the VI-B system and to determine the targeting rules for the VI-B1 locus from B. zoohelcum, we developed an E. coli essential gene screen ( Figure 3A ). For this negative selection screen, we generated a library of 54,600 unique spacers tiled with single-nucleotide resolution over the coding region of 45 monocistronic essential genes (Gerdes et al., 2003; Baba et al., 2006) , plus 60 nt into the 5' and 3' UTRs. We also included 1100 randomly generated non-targeting spacers to establish baseline activity. We then transformed this library with plasmids carrying bzcas13b (cas13b gene from B. zoohelcum) and bzcsx27, just bzcas13b, or a control empty vector. After quality-control-filtering of all screened spacers (Experimental Procedures), we found a statistically significant depletion of targeting spacers over non-targeting spacers, indicating that Cas13b, alone or with Csx27, can achieve nucleic acid interference ( Figure 3B ).
To assess the targeting rules for Cas13b, we established two spacer depletion levels: strongly depleted (top 1% of depleted spacers) and safely depleted (spacers depleted 5s above the mean depletion of the filtered non-targeting spacers). From spacers passing the strongly depleted cutoff we derived sequence motifs qualitatively identifying a double-sided protospacer flanking sequence (PFS) ( Figure 3C ). Because each position in a sequence weblogo is assumed to be independent, we developed a more quantitative, base-dependent PFS score defined as the ratio of the number of safely depleted spacers to the number of all spacers with a given PFS, normalized across all PFS scores ( Figure 3D ). 8 The normalized PFS scores revealed a 5' PFS of D (A, U, or G) and 3' PFS of NAN or NNA, consistent for Cas13b with Csx27, as well as for Cas13b alone. To validate these sequencetargeting rules, we performed an orthogonal depletion screen with Cas13b alone, targeting the Kanamycin resistance gene (Figures 3E, 3F ). Four classes of spacers were created: non-targeting, targeting with both 5' and 3' PFS rules, targeting with only the 5' or 3' PFS rule, and targeting with neither rule. Consistent with our findings from the E. coli essential gene screen, the 5' and 3' PFS spacers resulted in the highest Kanamycin sensitivity ( Figures 3G, S7 ). interferes with RNA. We confirmed this by demonstrating that purified Cas13b exclusively cleaves single-stranded RNA with both direct repeat architectures ( Figures 4A, S8A ). We then validated the PFS targeting rules biochemically, showing that a 5' PFS of C greatly inhibits single-stranded RNA cleavage ( Figure 4B ), whereas a 3' PFS of NAN or NNA enhances this activity ( Figure 4C ).
BzCas13b cleaves single-stranded RNA and exhibits collateral activity in vitro
Other HEPN domain-containing CRISPR-Cas RNA-targeting systems, such as Csx1 from the Type III-B CRISPR-Cas systems, preferentially cleave targets containing specific singlestranded nucleotides (Sheppard et al., 2016) . To determine if Cas13b exhibits such a preference, we tested an RNA substrate with a variable homopolymer loop outside of the spacer:protospacer duplex region ( Figure 4D ). We observed cleavage at pyrimidine residues, with a strong 9 preference for uracil. This activity is abolished in the presence of EDTA ( Figure S8B ), suggesting a divalent metal ion-dependent mechanism for RNA cleavage akin to that of a similar HEPN-containing, Class 2 effector protein, Cas13a (Abudayyeh et al, 2016 ; East-Seletsky et al., 2016) .
Given that Cas13a has also been reported to cleave RNA non-specifically once activated by interaction with the target ("collateral effect") (Abudayyeh et al., 2016 ; East-Seletsky et al., 2016) , we sought to test the ability of Cas13b to cleave a second, non-specific substrate following target cleavage. Using an in vitro assay similar to the one we previously used with Cas13a (Abudayyeh et al., 2016) , we incubated Cas13b-crRNA complexes with both a target and non-target RNA substrate. We observed collateral cleavage of the non-targeted RNA, but only in the presence of the target RNA ( Figure 4E ).
Cas13b shows robust HEPN-dependent interference and is repressed by Csx27 activity
To validate RNA interference in vivo, we assayed interference against the lytic, single-stranded RNA bacteriophage MS2, whose life cycle contains no DNA intermediates. We performed an MS2 drop plaque assay at serial dilutions of phage for both bzcas13b with bzcsx27 and bzcas13b alone with three spacers targeting the MS2 genome, two at the lys-rep interface and one in rep, as well as one non-targeting spacer ( Figure 5A ). We observed substantial reduction in plaque formation for all targeting spacers compared to the non-targeting spacer, confirming sequencespecific RNA targeting by VI-B1 systems. (Figures 5A, S9) . Notably, the presence of bzcsx27 weakened RNA interference by bzcas13b for all three spacers.
To confirm the lack of DNA interference in vivo, we modified an existing plasmid interference assay with a protospacer placed either in-frame at the 5' end of the bla ampicillin-resistance gene (transcribed target) or upstream of the bla gene promoter (non-transcribed target). Bacteria cotransformed with bzcas13b and spacer as well as the non-transcribed target plasmid survived at a comparable rate to co-transformation of the same target with the empty vector on dual antibiotic selection. For bacteria co-transformed with the transcribed target, the colony forming unit rate under dual antibiotic selection was reduced by ~2 orders of magnitude in the presence of bzcas13b, corroborating that Cas13b exclusively targets RNA in vivo ( Figure 5B ).
We next tested if predicted catalytic residues in the HEPN domains were responsible for RNA cleavage by Cas13b. Three HEPN mutants were obtained by replacing the conserved catalytic arginines and histidines in the two HEPN domains with alanines (R116A/H121A, termed domain 1 (D1); R1177A/H1182A, termed domain 2 (D2); and R116A/H121A/R1177A/H1182A, termed quadruple (Q)) ( Figure S6 ). All mutants lacked observable cleavage activity ( Figure 5C ), yet retained RNA binding capacity in vitro ( Figure 5D , S10A). The wildtype and all three HEPN mutant Cas13b proteins showed comparable binding affinities for a single-stranded target RNA substrate, with K D values ranging from 17nM to 24nM ( Figure 5D , S10A). The K D for off-target binding was found to be greater than 188nM ( Figure S10B ).
We confirmed the involvement of the HEPN domains in RNA interference in vivo, finding ~5.5 orders of magnitude decrease in resistance to MS2 phage in the quadruple HEPN mutants versus wildtype Cas13b ( Figures 5E, S9 ). Interestingly, quadruple mutant Cas13b with spacers 2 and 3 still showed weak phage resistance, potentially due to catalytically inactive Cas13b binding to phage genomic RNA, leading to reduced phage replication.
Computational modeling predicts additional targeting rules governing Cas13b
Our sequence-based targeting results from the E. coli essential gene screen implied the existence of additional RNA-targeting rules beyond the PFS (only ~18% of spacers were safely depleted for bzcas13b; from the PFS rules alone, the expected value would be ~33%). Given that RNA targets contain a variety of secondary structures, we sought to determine how RNA accessibility impacts targeting. Using the Vienna RNAplfold method (Bernhart et al., 2006) , which has been successfully employed to predict RNAi efficiency (Tafer et al., 2008 ) ( Figure 6A ), we trained and tested an RNA accessibility model for spacer efficiency on our screen data, and found that RNA accessibility matters the most in the protospacer region most distal to the direct repeat of the crRNA (Figures 6B, 6C ).
Given the collateral activity observed in vitro, we examined our screen data for indications of non-specific RNA cleavage by Cas13b. To this end, we calculated the empirical cumulative distribution functions of safely depleted spacers aggregated across all essential genes from the 5' UTR into the gene and from the 3' UTR into the gene ( Figure 6D ). Because cleavage closer to the 5' UTR is more likely to disrupt gene function, without non-specific RNase activity, we would expect an overrepresentation of spacers in the 5' UTR and an underrepresentation in the 3' UTR. By contrast, in the presence of collateral activity a nearly uniform distribution would be expected. From our screen data, we observed only a marginal underrepresentation of spacers in the 3' UTR compared to a uniform distribution, suggesting that collateral activity may occur in vivo.
CRISPR-Cas13b effectors are differentially regulated by Csx27 and Csx28
To determine if the established RNA targeting rules generalize across the subtype VI-B systems from diverse bacteria, we characterized the subtype VI-B2 locus from P. buccae. RNA sequencing of the CRISPR array revealed processing effectively identical to that of B. zoohelcum, excluding the long crRNA ( Figure S11 ). The E. coli essential gene screen with pbcas13b and pbcsx28 or pbcas13 alone led to the identification of a PFS matrix similar to that of B. zoohelcum, with certain PFS's disfavored (Figures 7A, S12). Similar to BzCas13b, PbCas13b was found to cleave targeted single-stranded RNA in vitro ( Figure S8C ). As with bzcsx27, the presence of pbcsx28 did not appreciably alter the PFS. We also repeated the secondary structure analysis with pbcas13b, and a comparable RNAplfold model applied (Figures S13A, S13B). Strikingly, in these experiments, the safely depleted spacers for pbcas13b alone were highly biased to the beginning of the 5' UTR of genes, suggestive of inhibited or more spatially localized RNase activity in the absence of pbcsx28 ( Figure S13C ). We further explored the apparent reduced activity of pbcas13b alone relative to the respective full CRISPR-Cas locus using the MS2 phage plaque drop assay and found that pbcsx28 enhances MS2 phage interference by up to four orders of magnitude ( Figures 7B, S9 ). The differential ability of csx27 to repress and csx28 to enhance cas13b activity generalizes across thousands of spacers in the E. coli essential gene screen ( Figure 7C ), highlighting the distinctive regulatory modes of the two variants of subtype VI-B CRISPR-Cas systems.
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To further explore the ability of the small accessory proteins to modulate Cas13b activity, we tested if Csx27 can also repress PbCas13b using the MS2 drop plaque assay. Cells cotransformed with pbcas13b and bzcsx27 expression plasmids exhibited a 10 5 fold reduction in interference activity relative to pUC19 empty vector, suggesting that Csx27 exerts an inhibitory effect on PbCas13b ( Figures 7D, S9 ). The ability of Csx27 to modulate the interference activity of BzCas13b and PbCas13b suggests that it is a modular protein that can function across multiple VI-B loci ( Figure 7E ).
DISCUSSION
Here we describe two RNA-targeting CRISPR Class 2 systems of subtype VI-B (VI-B1 and VI- Csx28 (VI-B2 systems), which exhibit opposing regulatory effects on Cas13b activity. Repression of Cas13b by Csx27 in VI-B1 systems could be part of an important regulatory mechanism of phage interference. The ability of Csx27 to repress Cas13b activity may be a general property, as we found that it can also repress PbCas13b (subtype VI-B2). In the case of type VI-B2 systems, Csx28 might enhance the collateral activity of Cas13b to inactivate numerous transcripts of invading bacteriophages or to promote programmed cell death. Both Csx27 and Csx28 contain predicted long, hydrophobic α-helices that might enable them to physically interact with Cas13b, but this remains to be determined. We did not find any instances of Csx27 or Csx28 encoded outside type VI-B loci, suggesting that these proteins might function in tight cooperation with Cas13b.
As with previously characterized Class 2 CRISPR-Cas effectors, such as Cas9 and Cpf1, there is enormous potential to harness Cas13b for use as a molecular tool. A holistic understanding of the factors that affect target selection is essential to the success of any such tools, particularly those that target RNA, where secondary structure will likely impact activity. We therefore developed an E. coli essential gene screen to fully explore the targeting rules of Cas13b. This E. coli screen offers several advantages by increasing the number of guides testable in a single experiment to explore how diverse spacer and flanking sequences may affect Cas13b activity. This screen revealed a double-sided PFS in VI-B systems, which may give insight into Cas13b protein-RNA interactions, and could help improve specificity by expanding sequence targeting constraints (Ran et al., 2015) .
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The characterization of Cas13b and other RNA-targeting CRISPR systems raises the prospect of a suite of precise and robust in vivo RNA manipulation tools for studying a wide range of biological processes (Filipovska et al., 2011; Mackay et al., 2011; Abil et al., 2015) . The ability of Cas13b to process its own CRISPR array could be extended to multiplex transcriptome engineering. In addition, the VI-B functional long direct repeats could be altered to incorporate stem loops akin to the Cas9-SAM system (Konermann et al., 2015) . Like Cas9 and Cpf1, Cas13a and Cas13b may be utilized for complementary applications in science and technology. 
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EXPERIMENTAL PROCEDURES
Computational Sequence Analysis
RFP-Tagged Protein Fluorescent Imaging
One Shot Stbl3 Chemically Competent E. coli were transformed with plasmids containing RFP (negative control) or RFP fused to the N-or C-terminus of Csx27 of B. zoohelcum or Csx28 of P.
buccae (Table S1 ). Clones were cultured up in 5mL of antibiotic LB overnight, then spun down at 5000g and resuspended in PBS with 1% methanol-free formaldehyde. After 30 minutes fixation, cells were washed once with PBS and then diluted 1:2 in PBS. 5uL of sample was pipetted onto a silane-coated slide, which was covered with a coverslip. Fluorescent imaging was performed in a 63x objective microscope with oil immersion.
Bacterial RNA-Sequencing
RNA was isolated and prepared for sequencing using a previously described protocol (Shmakov et al., 2015; Heidrich et al., 2015) . For RNA sequencing native B. zoohelcum ATCC 43767 grown under the same conditions, we repeated the experiment with a modified protocol, omitting TAP prior to 5' adapter ligation, to promote enrichment of processed transcripts originating from the CRISPR array. For heterologous P. buccae ATCC 33574 RNA sequencing in E. coli, we cloned the locus into pACYC184 (Table S1 ).
The prepared cDNA libraries were sequenced on a MiSeq (Illumina). Reads from each sample were identified on the basis of their associated barcode and aligned to the appropriate RefSeq reference genome using BWA (Li and Durbin, 2009 ). Paired-end alignments were used to extract entire transcript sequences using Galaxy (https://usegalaxy.org), and these sequences were analyzed using Geneious 8.1.8.
E. coli Essential Gene Screen Experiment
The intersection of two E. coli DH10B strain essential gene studies (Gerdes et al., 2003; Baba et al., 2006) was taken, and further pared down to 45 genes by only selecting genes exclusive to their respective operons (Table S2) . Over these 45 genes 54,600 spacers were designed to tile at single resolution across the coding region, as well as to extend 60nt into the 5' UTR and 3'UTR.
In addition, 1100 non-targeting, pseudorandomly generated spacers with no precise match to the E. coli DH10B strain genome were added to the library as a non-targeting negative control. The library of spacers (Table S3) 
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E. coli Essential Gene Screen Analysis
Prepared DNA libraries were sequenced on a NextSeq (Illumina), with reads mapped to the input library of spacers. Spacer depletions were calculated as the read abundance of a spacer in the empty vector condition divided by read abundance in each gene plasmid condition. Mean depletions over three bioreplicates were calculated. We imposed a two-step quality-control filter on the data: a maximum coefficient of variation of 0.2 for depletion over three bioreplicates, and a minimum spacer read abundance of 1/3N in each bioreplicate, where N = 55,700. Weblogos of the strongly depleted (top 1% depleted) spacers were generated (Crooks et al., 2004) , and from each identified PFS, heatmaps of the ratio of safely depleted (>5s above mean depletion of nontargeting spacers) spacers to all spacers in the screen were generated. For spatial analysis via empirical cumulative distribution functions, safely depleted spacers were aggregated across the first or last 250nt of genes.
For secondary structure analysis, we utilized the RNA accessibility model from Vienna
RNAplfold (Bernhart et al., 2006) . RNAplfold calculates through a moving average of RNA folds the probability that a region u of RNA is unpaired given its cis sequence context in a fourparameter model, where W is the moving average window length in nucleotides, L is the maximum permissible pairing distance between nucleotides in the window, and u start and u end are the start and end of the region u, respectively. To apply this model to our data, we separated spacers from our E. coli essential gene screen into training/testing cohorts of five or more, each represented by a unique permissible PFS and gene and containing at least one spacer in the top 2% of depleted spacers from the screen (to enhance predictive signal). We then randomly 20 divided these cohorts into a training set (~80%) and a testing set (~20%). For optimizing a secondary structure-mediated model of efficient spacer design we selected as objective functions top 1 or top 3 accuracy, the percent of cohorts for which the top spacer is accurately predicted or falls in the top 3 depleted spacers in a cohort, respectively. We optimized the two objective functions on the training data set, first by fixing W and L while varying u start and u end , then by fixing u start and u end and varying W and L ( Figure 4B ). In the case of bzcas13b with bzcsx27, as well as that of bzcas13b alone, the optimized parameters were found to be approximately W = 240, L = 180, u start = 16, and u end = 30. We gauged the performance of this RNAplfold model relative to 10 6 Monte Carlo simulations performed on the testing data set and found empirical Pvalues of less than 1e-2 for top 1 accuracy, and less than 1e-5 for top 3 accuracy. Similar predictive power applied to pbcas13b with pbcsx28, as well as to pbcas13b alone.
Kanamycin Validation Screen Experiment
A total of 160 kanamycin-targeting spacers was selected, 42 of which contain both PFS rules, 47 of which contain one rule, and 71 of which contain no rules, to which 162 non-targeting control spacers were added (Table S4) 
Kanamycin Validation Screen Analysis
Prepared DNA libraries were sequenced on a NextSeq (Illumina), with reads mapped to the input library of spacers. For normalizing the abundance of spacers of two separate clonings, the corrected experimental read abundance of a given spacer was calculated as the read abundance of that spacer in the bzcas13b plasmid (kanamycin-chloramphenicol transformation) multiplied by the ratio of the read abundance ratio of that spacer in the non-bzcas13b plasmid (chloramphenicol-only transformation) to the read abundance ratio of that spacer in the bzcas13b plasmid (chloramphenicol-only transformation).
MS2 Phage Drop Plaque Assay
Individual spacers for MS2 interference were ordered as complementary oligonucleotides containing overhangs allowing for directional cloning in between two direct repeat sequences in vectors containing cas13b (Tables S1, S5). 10 uM of each complementary oligo were annealed in 10X PNK Buffer (NEB), supplemented with 10mM ATP and 5 units of T4PNK (NEB). Oligos were incubated at 37C for 30 min., followed by heating to 95C for 5 min. and then annealed by cooling to 4C. Annealed oligos were then diluted 1:100 and incubated with 25 ng of Eco31I using csx27 or csx28, C3000 cells harboring these plasmids were made competent and then transformed with cas13b direct repeat-spacer-direct repeat plasmids. Following transformation, individual clones were picked and grown overnight in LB containing the appropriate antibiotics.
The following morning, cultures were diluted 1:100 and grown to an OD 600 of 2.0, then mixed with 4mL of antibiotic containing Top Agar (10 g/L tryptone, 5 g/L yeast extract, 10 g/L sodium chloride, 5 g/L agar) and poured on to LB-antibiotic base plates. 10 fold serial-dilutions of MS2 phage were made in LB and then spotted onto hardened top agar with a multi-channel pipette.
For assessing interference levels in Figures 5E and 7D , samples were blinded using a key and the lowest dilution of phage at which plaque formation occurred was compared to a pACYC condition by eye, where the lowest dilution of MS2 that formed plaques on pACYC was set to 1.
The lowest dilution of phage used for Figure 5E was 1.05*10 8 pfu.
DNA Interference Assay
A 34-nt target sequence consisting of a 30-nt protospacer and a permissive PFS (5'-G, 3'-AAA) was cloned into pUC19 in two locations (Tables S1, S5). For the transcribed target, the target sequence was cloned into the coding strand of the bla gene, in frame immediately after the start codon, with the G of the start codon serving as the 5' PFS. For the non-transcribed target the identical target sequence (protospacer and PFS) were cloned into the AatII site of pUC19, so that the protospacer appears on the non-transcribed strand with respect to the pBla and pLac promoters. To determine interference, 25 ng of the ampicillin resistant target plasmid and 25 ng of the chloramphenicol resistant bzcas13b or empty vector (pACYC) were added to 5 uL of NovaBlue GigaSingle cells (Novagen). The cells were incubated for 30 minutes on ice, heatshocked for 30 seconds at 42°C and incubated on ice for 2 minutes. Then, 95 uL of SOC was added to cells and they were incubated with shaking at 37°C for 90 minutes, before plating the entire outgrowth (100 uL) on plates containing both chloramphenicol and ampicillin.
BzCas13b Protein Purification
The mammalian codon-optimized gene for Cas13b (B. zoohelcum) was synthesized (GenScript) and inserted into a bacterial expression vector (6x His/Twin Strep SUMO, a pET based vector received as a gift from Ilya Finkelstein) after cleaving the plasmid with the BamHI and NotI restriction enzymes and cloning in the gene using Gibson Assembly® Master Mix (New England Biolabs). The BzCas13b expression construct (Table S1) 
BzCas13b HEPN Mutant Protein Purification
Alanine mutants (Table S1 ) at each of the HEPN catalytic residues were generated using the Q5® site-directed mutagenesis kit (New England Biolabs) and transformed into One Shot® BL21(DE3)pLysE cells (Invitrogen). For each mutant, 1 L of Terrific Broth was used to generate cell paste and all other reagents were scaled down accordingly. Protein purification was performed using the same protocol as wild-type Cas13b.
PbCas13b Protein Purification
PbCas13b (Prevotella buccae) was cloned into the same pET based vector and purified using a similar protocol as BzCas13b with the following differences: cells were grown at 21°C for 18 hours. Frozen cell paste was resuspended into 500 mM NaCl, 50 mM HEPES 7.5 and 2 mM 25 DTT prior to breaking cells in the microfluidizer. The Superdex 200 column was run in 500 mM NaCl, 10 mM HEPES 7.0, and 2 mM DTT.
Nucleic Acid Preparation
For in vitro synthesis of RNA, a T7 DNA fragment must be generated. To create T7 DNA fragments for crRNAs, top and bottom strand DNA oligos were synthesized by IDT. The top DNA oligo consisted of the T7 promoter, followed by the bases GGG to promote transcription, the 30-nt target and then direct repeat. Oligos were annealed together using annealing buffer (30 mM HEPES pH 7.4, 100 mM potassium acetate, and 2 mM magnesium acetate). Annealing was performed by incubating the mixture for 1 minute at 95°C followed by a -1°C/minute ramp down to 23°C. To create ssRNA targets, short targets (Trunc2, 3, 4) were synthesized as top and bottom strand oligos containing the T7 promoter. For long ssRNA targets (E1, E2, S and L CRISPR Arrays), DNA primers (Table S8 ) with a T7 handle on the forward primer were ordered and the DNA fragment was amplified using PCR. T7 DNA constructs for RNA generation without body labeling were incubated with T7 polymerase overnight (10-14 hours) at 30°C using the HiScribe T7 Quick High Yield RNA Synthesis kit (New England Biolabs). Body-labeled constructs were incubated with Cyanine 5-UTP (Perkin Elmer) and incubated with T7 polymerase overnight at 30°C using the HiScribe T7 High Yield RNA Synthesis kit (New England Biolabs). For a complete list of crRNAs used in this study see Table S6 . For a complete list of targets used in this study see table S7. 5' end labeling was accomplished using the 5' oligonucleotide kit (VectorLabs) and with a maleimide-IR800 probe (LI-COR Biosciences). 3' end labeling was performed using a 3' oligonucleotide labeling kit (Roche) and Cyanine 5-ddUTP (Perkin Elmer). RNAs were purified using RNA Clean and Concentrator columns TM -5 (Zymo Research). Body-labeled dsRNA substrates were prepared by T7 DNA fragments for the bottom and top RNA strand. After synthesis, 1.3-fold excess of non-labeled bottom strand ssRNA was added and re-annealed to ensure the top strand would be annealed to a bottom strand by incubating the mixture for 1 minute at 95°C followed by a -1°C/minute ramp down to 23°C.
Nuclease Assay
Nuclease assays were performed with equimolar amounts of end-labeled or body-labeled ssRNA target, purified protein, and crRNA, for targeted ssRNA cleavage. For CRISPR array cleavage, protein was supplied in a four times molar excess of the CRISPR array. Reactions were incubated in nuclease assay buffer (10 mM TrisHCl pH 7.5, 50 mM NaCl, 0.5 mM MgCl 2 , 0.1% BSA). Reactions were allowed to proceed at 37°C for times specified in the figure legends.
After incubation, samples were then quenched with 0.8U of Proteinase K (New England Biolabs) for 15 minutes at 25°C. The reactions were mixed with equal parts of RNA loading dye (New England Biolabs) and denatured at 95°C for 5 minutes and then cooled on ice for 2 minutes.
Samples were analyzed by denaturing gel electrophoresis on 10% PAGE TBE-Urea (Invitrogen) run at 45°C. Gels were imaged using an Odyssey scanner (LI-COR Biosciences).
EMSA Assay
For the Electrophoretic Mobility Shift Assay (EMSA), binding experiments were performed with a series of half-log complex dilutions (crRNA and BzCas13b) from .594 to 594 nM. Binding assays were performed in nuclease assay buffer supplemented with 10 mM EDTA to prevent cutting, 5% glycerol, and 5µg/mL heparin in order to avoid non-specific interactions of the complex with target RNA. Protein was supplied at two times the molar amount of crRNA. 
Figure Legends
Figure S4 | Predicted secondary structure of type VI-B direct repeats is well-conserved. (A)
Predicted secondary structure folds of structurally unique CRISPR class 2 type VI-B1 direct repeats (Vienna RNAfold). (B) Predicted secondary structure folds of structurally unique CRISPR Class 2 type VI-B2 direct repeats. 
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